You can also request for sample page of abovemention reports on Customersupport@aarkstore.com
Price :$ 2000 - PDF | $ 4000 - Site Licence | $ 6000 - Corporate LicencePages : 286
SummaryGlobal Markets Direct’s, Cognitive Disorders - Pipeline Review, H2 2012,provides an overview of the indication’s therapeutic pipeline. This reportprovides information on the therapeutic development for Cognitive Disorders,complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for Cognitive Disorders. Cognitive Disorders - Pipeline Review, HalfYear is built using data and information sourced from Global Markets Direct’sproprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’steam.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.
Scope- A snapshot of the global therapeutic scenario for Cognitive Disorders. - A review of the Cognitive Disorders products under development by companiesand universities/research institutes based on information derived from companyand industry-specific sources. - Coverage of products based on various stages of development ranging fromdiscovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Cognitive Disorders.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.- Plan mergers and acquisitions effectively by identifying players of the mostpromising pipeline.
Table Of ContentsList of Tables 7List of Figures 9Introduction 10Global Markets Direct Report Coverage 10Cognitive Disorders Overview 11Therapeutics Development 12An Overview of Pipeline Products for Cognitive Disorders 12Cognitive Disorders Therapeutics under Development by Companies 14Cognitive Disorders Therapeutics under Investigation byUniversities/Institutes 20Late Stage Products 24Comparative Analysis 24Mid Clinical Stage Products 25Comparative Analysis 25Early Clinical Stage Products 26……………………………
For More details about above & other Reportsplz contact :LavanyaAarkstore.comContact: Marketing teamMob.No.918149852585Email: firstname.lastname@example.orgURL: http://www.aarkstore.comhttp://in.linkedin.com/in/aarkstorehttp://www.facebook.com/aarkstore